CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF PSYCHOTROPIC DRUGS IN EPILEPSY

Article Sidebar

PDF (English)
Выпуск: Том 4 № 12 Part 2 : Евразийский журнал академических исследований
Раздел: Статьи
Опубликован:
Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.

Main Article Content

Assistant intern at the Department of "Pharmacology, clinical pharmacology and medical biotechnologies", ASMI
info@in-academy.uz

Аннотация:

The aim of the work is to present clinical characteristics of depressive and anxiety disorders in epilepsy and to substantiate modern psychopharmacotherapy of these disorders. Based on literature data and our own research, the features of affective symptoms characteristic of epilepsy are shown, the significance of cognitive impairment with impaired executive functions is emphasized. A comparison of clinical manifestations of depressive and anxiety disorders with localization and lateralization of the epileptic focus, the factor of the leading hand and the presence of alexithymia is carried out.

Article Details

Как цитировать:

Parpieva , S. (2024). CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF PSYCHOTROPIC DRUGS IN EPILEPSY. Евразийский журнал академических исследований, 4(12 Part 2), 65–68. извлечено от https://in-academy.uz/index.php/ejar/article/view/42308

Библиографические ссылки:

Brodie M.J., Shorvon S.D., Canger R., Halasz P., Johannessen S., Thompson P., Wieser H.G., Wolf P. Commission on European Affairs: appropriate standards of epilepsy care across Europe. Epilepsy. 2017;38(11):1245–1250. doi:10.1111/j.15281157.1997.tb01224.x

Hauser W.A. Incidence and prevalence. Epilepsy: A Comprehensive Textbook. Engel J., Pedley T.A. (Eds.). Lippincott-Raven: Philadelphia 2018:47–57.

Walker M.C., Sander J.W. New anti-epileptic drugs. Exp. Opin. Invest. Drug. 2019;8:1497–1510. doi: 10.1517/13543784.8.10.1497

Altschuler L.L., Devinsky O., Post R.M., Theodore W. Depression, anxiety and temporal lobe epilepsy: laterality of focus and symptomatology. Arch. Neurology. 2010;47:284–288. doi:10.1001/archneur.2010.00530030050016

Austin M.P., Mitchell P., Wilhelm K. et al. Cognitive function in depression: a distinct frontal impairment in melancholia? Psychological Medicine. 2019;29:73–85. DOI: 10.1017/S00332917980077888.